The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Metabolic reprogramming in clear cell renal cell carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
KEGG: new perspectives on genomes, pathways, diseases and drugs
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1092 · Cited by 8,865
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
KEGG as a reference resource for gene and protein annotation
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Antioxidants Accelerate Lung Cancer Progression in Mice
Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007653 · Cited by 867
Fatty acid synthase, a proficient multifunctional enzyme
Wakil, S. J. (1989) · Biochemistry · doi:10.1021/bi00437a001 · Cited by 820
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Hakimi, A. A., Reznik, E., Lee, C.-H., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 798
Positron-Emission Tomography and Assessment of Cancer Therapy
Juweid, M. E., & Cheson, B. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050276 · Cited by 750
The genetic basis of kidney cancer: a metabolic disease
Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 744
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 726
Targeting renal cell carcinoma with a HIF-2 antagonist
Chen, W., Hill, H., Christie, A., Kim, M. S., Holloman, E., Pavia-Jimenez, A., Homayoun, F., Ma, Y., Patel, N., Yell, P., et al. (2016) · Nature · doi:10.1038/nature19796 · Cited by 709
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Nickerson, M. L., Jaeger, E., Shi, Y., Durocher, J. A., Mahurkar, S., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4921 · Cited by 588
Regulation of the pentose phosphate pathway in cancer
Jiang, P., Du, W., & Wu, M. (2014) · Protein & Cell · doi:10.1007/s13238-014-0082-8 · Cited by 560
Enoch, H. G., Catalá, A., & Strittmatter, P. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33223-4 · Cited by 558
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497
HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Semenza, G. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.009 · Cited by 469
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Cho, H., Du, X., Rizzi, J. P., Liberzon, E., Chakraborty, A. A., Gao, W., Carvo, I., Signoretti, S., Bruick, R. K., Josey, J. A., et al. (2016) · Nature · doi:10.1038/nature19795 · Cited by 451
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
Lee, G. K., Park, H. J., Macleod, M., Chandler, P., Munn, D. H., & Mellor, A. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01526.x · Cited by 432
Jacque, N., Ronchetti, A. M., Larrue, C., Meunier, G., Birsen, R., Willems, L., Saland, E., Decroocq, J., Maciel, T. T., Lambert, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621870 · Cited by 387
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382
Indoleamine 2,3-dioxygenase. Purification and some properties
Shimizu, T., Nomiyama, S., Hirata, F., & Hayaishi, O. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30447-7 · Cited by 367
Miyamoto, S., Murphy, A. N., & Brown, J. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402285 · Cited by 339
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 328
Gameiro, P. A., Yang, J., Metelo, A. M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W. K., Olumi, A., López-Larrubia, P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.002 · Cited by 325
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Kaelin, W. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-sup-040025 · Cited by 318
VHL and HIF signalling in renal cell carcinogenesis
Baldewijns, M. M., van Vlodrop, I. J., Vermeulen, P. B., Soetekouw, P. M., van Engeland, M., & de Bruïne, A. P. (2010) · The Journal of Pathology · doi:10.1002/path.2689 · Cited by 316
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Venneti, S., Dunphy, M. P., Zhang, H., Pitter, K. L., Zanzonico, P., Campos, C., Carlin, S. D., La Rocca, G., Lyashchenko, S., Ploessl, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1009 · Cited by 312
Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Toschi, A., Lee, E., Gadir, N., Ohh, M., & Foster, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800170200 · Cited by 301
Wettersten, H. I., Hakimi, A. A., Morin, D., Bianchi, C., Johnstone, M. E., Donohoe, D. R., Trott, J. F., Aboud, O. A., Stirdivant, S., Neri, B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1703 · Cited by 293
Self-citationl -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280
Modeling Adult Gliomas Using RCAS/t-va Technology
Hambardzumyan, D., Amankulor, N. M., Helmy, K. Y., Becher, O. J., & Holland, E. C. (2009) · Translational Oncology · doi:10.1593/tlo.09100 · Cited by 280
Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier
Carman, A. J., Mills, J. H., Krenz, A., Kim, D.-G., & Bynoe, M. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3337-11.2011 · Cited by 276
von Roemeling, C. A., Marlow, L. A., Wei, J. J., Cooper, S. J., Caulfield, T. R., Wu, K., Tan, W. W., Tun, H. W., & Copland, J. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3249 · Cited by 273
Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507228112 · Cited by 255
Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.
Björnsson, J., Short, M. P., Kwiatkowski, D. J., & Henske, E. P. (1996) · Europe PMC (PubMed Central) · Cited by 243
Pathway analysis of kidney cancer using proteomics and metabolic profiling
Perroud, B., Lee, J., Valkova, N., Dhirapong, A., Lin, P.-Y., Fiehn, O., Kültz, D., & Weiss, R. H. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-64 · Cited by 233
Self-citationArginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells
Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L.-J., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 217
PET Imaging of Inflammation Biomarkers
Wu, C., Li, F., Niu, G., & Chen, X. (2013) · Theranostics · doi:10.7150/thno.6592 · Cited by 200
Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma
Motzer, R. J., Bacik, J., & Mazumdar, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040031 · Cited by 186
King, S. C., Pollack, L. A., Li, J., King, J. B., & Master, V. A. (2014) · Journal of Urology · doi:10.1016/j.juro.2013.12.046 · Cited by 179
Argininosuccinate synthase: at the center of arginine metabolism.
(2011) · Europe PMC (PubMed Central) · Cited by 176
PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine
Lieberman, B. P., Ploessl, K., Wang, L., Qu, W., Zha, Z., Wise, D. R., Chodosh, L. A., Belka, G., Thompson, C. B., & Kung, H. F. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093815 · Cited by 176
Abnormal cholesterol metabolism in renal clear cell carcinoma
Gebhard, R. L., Clayman, R. V., Prigge, W. F., Figenshau, R., Staley, N. A., Reesey, C., & Bear, A. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38606-5 · Cited by 174
Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0942 · Cited by 170
Serotonin release varies with brain tryptophan levels
Schaechter, J. D., & Wurtman, R. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91761-5 · Cited by 169
Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165
Quantitative assessment of tumor metabolism using FDG-PET imaging
Weber, W. A., Schwaiger, M., & Avril, N. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00141-4 · Cited by 165
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
Schmidinger, M. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.016 · Cited by 165
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
White, N. M. A., Khella, H. W. Z., Grigull, J., Adzovic, S., Youssef, Y. M., Honey, R. J., Stewart, R., Pace, K. T., Bjarnason, G. A., Jewett, M. A. S., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.401 · Cited by 163
The metabolic basis of kidney cancer
Linehan, W. M., & Ricketts, C. J. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.002 · Cited by 162
Singer, K., Kastenberger, M., Gottfried, E., Hammerschmied, C. G., Büttner, M., Aigner, M., Seliger, B., Walter, B., Schlösser, H., Hartmann, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25543 · Cited by 160
Urine Metabolomic Analysis Identifies Potential Biomarkers and Pathogenic Pathways in Kidney Cancer
Kim, K., Taylor, S. L., Ganti, S., Guo, L., Osier, M. V., & Weiss, R. H. (2011) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2010.0094 · Cited by 159
Self-citationCellular Metabolism and Induced Pluripotency
Wu, J., Ocampo, A., & Belmonte, J. C. I. (2016) · Cell · doi:10.1016/j.cell.2016.08.008 · Cited by 155
Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 153
Tosaka, A., Ohya, K., Yamada, K., Ohashi, H., Kitahara, S., Sekine, H., Takehara, Y., & Oka, K. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39667-2 · Cited by 147
Urinary acylcarnitines are altered in human kidney cancer
Ganti, S. N., Taylor, S. L., Kim, K., Hoppel, C. L., Guo, L., Yang, J. C., Evans, C. P., & Weiss, R. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26274 · Cited by 144
Self-citationmiR-210: Fine-Tuning the Hypoxic Response
Ivan, M., & Huang, X. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_10 · Cited by 139
Jochéms, C., Fantini, M. C., Fernando, R. I., Kwilas, A. R., Donahue, R. N., Lepone, L. M., Grenga, I., Kim, Y., Brechbiel, M. W., Gulley, J. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9326 · Cited by 139
Heuer, T. S., Ventura, R., Mordec, K., Lai, J., Fridlib, M., Buckley, D., & Kemble, G. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.012 · Cited by 136
Chakrabarti, G., Moore, Z., Luo, X., Ilcheva, M., Ali, A., Padanad, M. S., Zhou, Y., Xie, Y., Burma, S., Scaglioni, P. P., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0137-1 · Cited by 133
Kidney cancer: Identification of novel targets for therapy
Weiss, R. H., & Lin, P.-Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000065 · Cited by 131
Self-citationSequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Kayani, I. A., Avril, N. E., Bomanji, J. B., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3309 · Cited by 129
Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122
Horiguchi, A., Asano, T., Asano, T., Ito, K., Sumitomo, M., & Hayakawa, M. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.04.135 · Cited by 121
Ma, W. W., Jacene, H. A., Song, D., Vilardell, F., Messersmith, W. A., Laheru, D. A., Wahl, R. L., Endres, C., Jimeno, A., Pomper, M. G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8383 · Cited by 117
Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
Robey, I., Stephen, R. M., Brown, K. S., Baggett, B. K., Gatenby, R. A., & Gillies, R. J. (2008) · Neoplasia · doi:10.1593/neo.07724 · Cited by 115
Metabolic profiling reveals key metabolic features of renal cell carcinoma
Catchpole, G., Platzer, A., Weikert, C., Kempkensteffen, C., Johannsen, M., Krause, H., Jung, K., Miller, K., Willmitzer, L., Selbig, J., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00939.x · Cited by 114
Real-Time Imaging of HIF-1α Stabilization and Degradation
Moroz, E., Carlin, S., Dyomina, K., Burke, S., Thaler, H., Blasberg, R., & Serganova, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005077 · Cited by 113
Grade-dependent Proteomics Characterization of Kidney Cancer
Perroud, B., Ishimaru, T., Borowsky, A. D., & Weiss, R. H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800252-mcp200 · Cited by 111
Self-citationIDO inhibitors move center stage in immuno-oncology
Sheridan, C. (2015) · Nature Biotechnology · doi:10.1038/nbt0415-321 · Cited by 110
Synergy in tumor suppression by direct interaction of Neutral Endopeptidase with PTEN
Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., Georgescu, M., & Nanus, D. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00331-3 · Cited by 109
p53 Pathway in Renal Cell Carcinoma Is Repressed by a Dominant Mechanism
Gurova, K. V., Hill, J. E., Razorenova, O. V., Chumakov, P. M., & Gudkov, A. V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1541 · Cited by 108
Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
Gatto, F., Miess, H., Schulze, A., & Nielsen, J. (2015) · Scientific Reports · doi:10.1038/srep10738 · Cited by 100
The Nephrologist’s Tumor: Basic Biology and Management of Renal Cell Carcinoma
Hu, S. L., Chang, A., Perazella, M. A., Okusa, M. D., Jaimes, E. A., Weiss, R. H., & for the American Society of Nephrology Onco-Nephrology Forum (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121335 · Cited by 91
Self-citationNovel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83
Ueno, D., Yao, M., Tateishi, U., Minamimoto, R., Makiyama, K., Hayashi, N., Sano, F., Murakami, T., Kishida, T., Miura, T., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-162 · Cited by 76
Valera, V., Walter, B. A., Linehan, W. M., & Merino, M. J. (2011) · Journal of Cancer · doi:10.7150/jca.2.515 · Cited by 76
Renal cancer in von Hippel–Lindau disease and related syndromes
Bausch, B., Jilg, C. A., Gläsker, S., Vortmeyer, A. O., Lützen, N., Anton, A., Eng, C., & Neumann, H. P. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.144 · Cited by 73
Precision medicine from the renal cancer genome
Riazalhosseini, Y., & Lathrop, M. G. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.133 · Cited by 69
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Trott, J. F., Kim, J. J., Aboud, O. A., Wettersten, H. I., Stewart, B. J., Berryhill, G. E., Uzal, F. A., Hovey, R. C., Chen, C., Anderson, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11658 · Cited by 65
Self-citationNakaigawa, N., Kondo, K., Tateishi, U., Minamimoto, R., Kaneta, T., Namura, K., Ueno, D., Kobayashi, K., Kishida, T., Ikeda, I., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2097-4 · Cited by 59
Expression of GLUT1 in Primary Renal Tumors: Morphologic and Biologic Implications
Özcan, A., Shen, S. S., Zhai, Q. “., & Truong, L. D. (2007) · American Journal of Clinical Pathology · doi:10.1309/hv6njvrqkk4qhm9f · Cited by 51
Arginine deprivation therapy for malignant melanoma
Kim, K., Yoon, Y., Frankel, A. E., Feun, & Ekmekcioglu (2012) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s37350 · Cited by 50
Meric‐Bernstam, F., Tannir, N. M., Mier, J. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.4568 · Cited by 41
Oncogenes: Implications for the Diagnosis and Treatment of Cancer
Cline, M. J., SLAMON, D. J., & Lipsick, J. S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-2-223 · Cited by 34
Mizuno, T., Kamai, T., Abe, H., Sakamoto, S., Kitajima, K., Nishihara, D., Yuki, H., Kambara, T., Betsunoh, H., Yashi, M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1097-0 · Cited by 34
Gofrit, O. N., & Orevi, M. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.02.2992 · Cited by 32
Renal-Cell Cancer — Targeting an Immune Checkpoint or Multiple Kinases
Quinn, D. I., & Lara, P. N. (2015) · New England Journal of Medicine · doi:10.1056/nejme1511252 · Cited by 24
Self-citationGupta, S. (2016) · Nature · doi:10.1038/537s100a · Cited by 22
Duivenvoorden, W., Beatty, L. K., Lhoták, Š., Hill, B., Mak, I. W. Y., Paulin, G. A., Gallino, D., Popović, S., Austin, R. C., & Pinthus, J. H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.574 · Cited by 20
Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma
Lee, H. J., Lee, H. Y., Lee, J. H., Lee, H., Kang, G., Song, J. S., Kang, J. K., & Kim, J. H. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.03.097 · Cited by 16
Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma
Yalniz, Z., Tigli, H., Tigli, H., Şanlı, Ö., Dalay, N., & Buyru, N. (2014) · Tumor Biology · doi:10.1007/s13277-014-2550-4 · Cited by 12
Molecular Imaging of Hypoxia-Inducible Factor 1α and von Hippel-Lindau Interaction in Mice
Choi, C. Y. H., Chan, D. A., Paulmurugan, R., Sutphin, P. D., Le, Q., Koong, A. C., Zundel, W., Gambhir, S. S., & Giaccia, A. J. (2008) · Molecular Imaging · doi:10.2310/7290.2008.00017 · Cited by 9
Cited by
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Bi, K., He, M. X., Bakouny, Z., Kanodia, A., Napolitano, S., Wu, J., Grimaldi, G., Braun, D. A., Cuoco, M. S., Mayorga, A., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.015 · Cited by 618
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
Metadata
- Authors
- Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H.
- Venue
- Nature Reviews Nephrology
- Published
- 2017-05-08
- Volume
- 13
- Issue
- 7
- Pages
- 410-419
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2613084028
- Cited by
- 571
- References
- 128
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.